Physician

Ajikumar V Aryangat, M.D.

According to 2025 Medicare claims, Ajikumar Aryangat, M.D. (NPI: 1407971856) practices endocrinology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is HEALTHTEXAS PROVIDER NETWORK (NPI: 1760488936; TIN: 752536818) and primary practice location at 75246-0930. Aryangat is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542), participating under the MSSP model.

Aryangat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 1,408 HCPCS/CPT codes, and received $86,168 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,741 prescription claims across 502 beneficiaries totaling $1,768,217 in drug costs, led by Ozempic (Semaglutide). DME data shows 301 claims. Open Payments data shows 77 records totaling $1,655. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $45,353 to $86,168. Similarly, Part D prescription costs have moved sharply higher in recent years, from $457,655 to $1,768,217. For DME billing, reported payments moved sharply higher in recent years, from $3,244 to $65,647.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	252	4,939	$45,353
2016	251	4,363	$50,029
2017	254	2,700	$49,653
2018	290	2,251	$58,237
2019	292	2,993	$51,221
2020	289	1,464	$54,577
2021	306	1,159	$75,767
2022	342	1,247	$79,502
2023	349	1,272	$80,757
2024	391	1,408	$86,168

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	191	1,732	$457,655
2016	183	1,808	$455,802
2017	200	1,869	$559,725
2018	247	2,100	$800,228
2019	261	2,383	$1,064,980
2020	282	2,495	$1,168,286
2021	347	2,697	$1,323,136
2022	402	3,258	$1,756,266
2023	454	3,500	$2,025,660
2024	502	3,741	$1,768,217

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	93	209	$4,225
2016	85	253	$8,084
2017	69	200	$9,364
2018	65	193	$8,945
2019	58	228	$21,887
2020	65	244	$28,838
2021	57	239	$33,258
2022	62	289	$43,616
2023	56	401	$66,215
2024	62	301	$69,094

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	54	54	$149
99443	Telephone medical discussion with physician, 21-30 minutes	20	20	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	371	757	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	30	32	$71
36415	Insertion of needle into vein for collection of blood sample	316	515	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	386	17,070	$561,661
Trulicity	Dulaglutide	140	5,724	$193,184
Mounjaro	Tirzepatide	121	4,004	$146,329
Tradjenta	Linagliptin	172	6,760	$113,252
Jardiance	Empagliflozin	96	5,464	$106,142

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	28	118	$42,674
E0784	External ambulatory infusion pump, insulin	Y	N/R	27	$9,198
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$5,358
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	21	$4,811
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	27	$4,268

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	77	$1,655	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajikumar V. Aryangat, M.D.?

Tedicare shows public-source Medicare data for Ajikumar V. Aryangat, M.D. (NPI 1407971856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajikumar V. Aryangat, M.D. have ACO affiliation data?

Ajikumar V. Aryangat, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542).

What billing organization is linked to Ajikumar V. Aryangat, M.D.?

Ajikumar V. Aryangat, M.D. is linked to HEALTHTEXAS PROVIDER NETWORK (billing NPI 1760488936) in the available physician profile data.

Does Ajikumar V. Aryangat, M.D. have Open Payments data?

Ajikumar V. Aryangat, M.D. has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.